No Data
Earnings Scheduled For February 27, 2025
RBC: The first half of the year is expected to welcome positive catalysts. COMPASS Pathways (CMPS.US) and 12 other mid-small pharmaceutical stocks are worth a look.
RBC believes that some important catalysts for small and mid-cap Biotechnology companies in the first quarter of 2025 may have a significant impact on the Stocks it covers.
Earnings Preview: PTCT to Report Financial Results Post-market on February 27
PTC Therapeutics to Participate in Upcoming Investor Conferences
PTC Therapeutics Receives Priority Review for Its Nervous System Disorder Treatment
TD Cowen Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Raises Target Price to $60
